Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lung Diseases × Exercise × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 214 Breast Neoplasms 119 Neoplasms 93 Prostatic Neoplasms 33 Fatigue 29 Obesity 23 Colorectal Neoplasms 21 Lung Neoplasms 17 Colonic Neoplasms 15 Polycystic Ovary Syndrome 14 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphedema 11 Lymphoma 10 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Hematologic Neoplasms 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Cardiotoxicity 8 Brain Neoplasms 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Overweight 6 Cognitive Dysfunction 6 Sarcopenia 5 Peripheral Nervous System Diseases 5 Lymphoma, Follicular 5

Interventions

Carboplatin 16 Pemetrexed 8 Paclitaxel 6 pembrolizumab 5 Cisplatin 5 Nivolumab 4 osimertinib 3 entinostat 3 atezolizumab 3 Erlotinib Hydrochloride 3 zipalertinib 2 selpercatinib 2 pralsetinib 2 durvalumab 2 camrelizumab 2 apatinib 2 One-Lung Ventilation 2 Ipilimumab 2 Bronchoscopy 2 Blood Specimen Collection 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1 toripalimab 1 taletrectinib 1 spartalizumab 1 sotorasib 1 sitravatinib 1 sintilimab 1 sacituzumab govitecan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04666558 2022-10-04

PiONEeR

University of Alberta

Phase NA Completed

Chronic Disease, Liver Diseases, Lung Diseases, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡